FDA Votes YES on Moderna Shots for Kids 6-17yo. Despite the Risk-Benefit Analysis Hides ‘Bad Data’
The U.S. Food and Drug Administration’s (FDA) vaccine advisory panel today voted unanimously to recommend Moderna’s COVID-19 vaccine for children ages 6 to 17 after determining the benefits of the vaccine outweigh the risks for use.
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 22 to 0 to recommend Moderna’s two-dose vaccine for 6- to 11-year-olds at half the strength of the adult version, and 22 to 0 in favor of authorizing the shot for 12- to 17-year-olds at the same strength as adults.
The FDA’s vaccine advisors will meet again on Wednesday to discuss amending Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine to include the “administration of the primary series to infants and children 6 months through 5 years of age.”
The committee tomorrow also will discuss amending EUA of the Pfizer-BioNTech vaccine to “include the administration of the primary series to infants and children 6 months through 4 years of age.”
After VRBPAC makes its recommendations, the FDA will then decide whether to authorize Moderna and Pfizer’s vaccines for the suggested age groups.
During the public comment session of the meeting, individuals expressed concern over recommending a vaccine for an age group that has an almost zero risk of experiencing severe illness or death from COVID-19 and has already acquired a high level of natural immunity.
Dr. Harvey Klein, orthopedic surgeon, mechanical engineer and rocket scientist said he is appalled at the FDA’s arrogance in even “thinking of vaccinating healthy children with outdated, highly toxic COVID vaccines.”
Klein said:
“Children have a “99.998% recovery rate with no sequelae if they get COVID. Vaccine Adverse Event Reporting System (VAERS) statistics show children ages birth to 18 who have been vaccinated with Pfizer-BioNTech and Moderna’s so-called vaccines have had severe life-threatening adverse reactions, such as myocarditis, Guillain-Barré Syndrome and many more severe adverse reactions [including] death.
“We know that VAERS is underreported by a factor of 100. The data cries out loudly to stop this insanity immediately before you kill or maim one more innocent child.”
Klein said the risks don’t outweigh the benefits as children from birth up to age 18 have a survival rate of 99.9% and virtually zero risk of death.
“Why in the world would you want to try to improve on perfection by exposing them to significant chances of being permanently severely injured or dead?” Klein asked. “The risk is infinite, the benefits are non-existent and the efficacy is extremely negative.”
Dr. David Gortler is a pharmacologist, pharmacist, FDA and healthcare policy oversight fellow and FDA reform advocate at the Ethics and Public Policy Center in Washington, D.C.
In a public comment published on the Ethics and Public Policy Center’s website, Gortler said the FDA and its advisory panel have “maintained a highly non-scientific and casual attitude toward approving a vaccine whose short- and long-term effects on children are unclear.”
Gortler said the FDA has failed to address genotoxicity, teratogenicity, oncogenicity of COVID-19 vaccines and cardiovascular risk following vaccination, potential fertility issues and clinical effectsof spike proteins in donated or transfused blood.
The U.S. Food and Drug Administration’s vaccine advisory council will meet June 14 to consider granting Emergency Use Authorization (EUA) of the Pfizer and Moderna COVID-19 vaccines for children under 5 years old, even though the White House last week announced it is already filling orders for the vaccines placed by states and healthcare providers. Click here to tell your members of Congress to oppose EUA of these vaccines for young children.
All links to Gospa News articles has been added after by editorial staff
The U.S. Food and Drug Administration (FDA) last week released its risk-benefit assessment of Moderna’s Emergency Use Authorization (EUA) application to inject mRNA into kids 0 to 17 years old.
I’ve been reading it for the past two days and here are the things that stood out to me.
Introduction, a shell game to hide the bad data
The risk-benefit document for Moderna is 190 pages single-spaced. It was released two business days before the June 14-15 Vaccines and Related Biological Products Advisory Committee, or VRBAC meeting.
A similar risk-benefit assessment for Pfizer’s EUA application for kids under 5 will be released today (just 24 hours before the meeting). This guarantees that NONE of the members of the VRBPAC will have read either of these documents before the meeting — which is exactly what the cartel wants.
664 Reports of Myocarditis in 5- to 17-Year-Olds After COVID Shots, VAERS Data Show in the US
One of the ways Moderna and the FDA rig the game is by adding endless layers of complexity to hide how bad the data really is.
This should have been four separate documents — Moderna in adolescents 12 to 17, Moderna in kids 6 to 11, Moderna in kids 2 to 5, and Moderna in kids 6 months to 23 months.Looked at individually, the shot fails in each of these four age groups. But lumping them together creates noise that makes it difficult to understand what’s going on.
Another really pernicious thing that Moderna does is to further subdivide these populations into eight different subpopulations (Randomization Set, Full Analysis Set, Immunogenicity Subset, Per-protocol Immunogenicity Subset, Per-protocol Set for Efficacy, Modified Intent-to-treat Set, MITT1 Set, Safety Set, Solicited Safety Set).
COVID VACCINES HOLOCAUST! 43,898 Deaths in the EU, 27,758 in the US. More than 5 million Injured
See what they did there? The public just wants to know — does the product work and what are the side effects?
By dividing the data into eight subcategories involving four different age groups now you have to wade through 32 different tables to try to make sense of what happened in the clinical trial.
They do something similar with the adverse events by dividing it across five tables x four age groups = 20 adverse event tables in all.
Subdividing the data in this way also allows Moderna to eliminate or hide data that it does not like. This is what people call “massaging the data” and it is unethical and a violation of scientific norms. We’ll return to this topic below.
No actual health benefits so Moderna/FDA use the immunobridging trick
The risks of COVID-19 are so low in the childhood population that there were ZERO severe cases of COVID-19 in either the treatment or the control group.
Therefore, the number needed to vaccinate, to prevent a single severe case of COVID-19 in the childhood population, is infinity. (Technically it’s undefined because you cannot divide by zero, but you take my point.)
The FDA and Centers for Disease Control and Prevention, or CDC guidance documents for how to write a risk-benefit assessment state that one must provide a number needed to treat, the absolute risk reduction, and the relative risk reduction.
Moderna just skipped all that because the cartel makes its own rules.
Moderna is in a race against natural immunity. But natural immunity has already won because 74.2% of kids had natural immunity by February — so by now, the number is probably closer to 100%.
The God-given immune system in kids has already done its part to stop the pandemic and now the FDA wants to mess that up to enrich the cartel and keep the pandemic going forever.
So how does Moderna/FDA claim that this shot was “effective”? They use an unethical statistical trick called “immunobridging.”
It makes me mad that I even have to explain it because it’s such junk science. But we all need to know exactly how the FDA rigged the process so that we can explain to the jury at Nuremberg 2 why these monsters should be convicted so here goes.
Remember, the Moderna shots produced NO reductions in severe outcomes because the risk of COVID-19 in this age group is infinitesimally small (see studies: here, here, here, and here).
So Moderna ignored the actual health outcomes and switched to looking at antibodies in the blood. In the process, they engaged in two egregious sleights of hand.
First, Moderna claims that the sample size for each of the four subgroups of children is about 3,000. But when it came to looking at antibodies in the blood, Moderna threw out about 90% of the sample and only looked at the bloodwork of about 300 kids in each age group.
No explanation was given for the criteria they used to exclude 90% of the sample from their analysis. We know that up to 30% of kids have no antibody response at all to COVID-19 shots so perhaps they actually started with a much larger sample and then threw out the data that showed no effect from the shot?
The second sleight of hand is that “no placebo recipients were included in the Immunogenicity Subset” (p. 26). Do you realize how huge this is? This is no longer an RCT at all — they did not include the bloodwork from anyone in the placebo group.
So the study cannot rule out the possibility that the increase in antibody levels was not from the vaccine at all but could have been from natural immunity. Just astonishing.
After these sleights of hand, Moderna then compares the antibody levels in the blood of about 10% of the children against the antibody levels in a sample of about 300 adults ages 18 to 25 enrolled in a previous clinical trial. If the antibody levels are similar (which they are), Moderna claims, ‘And therefore it will prevent disease in the future in kids!’
A few problems with that claim:
The Moderna study only measured antibody levels two months after the second dose — the time period when the antibody levels are at their peak (what Berenson calls “the happy valley”). But real-world experience with these vaccines shows that any efficacy quickly wanes to zero by six months and then goes NEGATIVE after that.
The second problem — and this is unresolvable and instantly disqualifying for Moderna — is that at the April 6 meeting of the FDA’s “expert advisory committee” one member after another acknowledged that there are no “correlates of protection” for these vaccines.
What that means in plain English is that you cannot use antibodies (or B-cells, T-cells, or any other proxy) to predict whether someone is immune or not.
Eric Rubin, who serves on that committee and is also the editor of the New England Journal of Medicine (NEJM) stated it bluntly:
“We know what kind of antibody response can be generated, we just don’t know if it works.”
You can watch it yourself in the video below.
The third problem is that the Moderna study was completed back in mid-2021 — when the original Wuhan and Alpha strains were prevalent. Since then, the Omicron variant has entirely replaced the original strains and real-world data show that both Moderna and Pfizer shots are not effective against the Omicron variant.
So in spite of all of the chicanery (discarding 90% of the sample, immunobridging, claiming correlates of protection that are not valid) Moderna cannot show any evidence that this shot will be effective against SARS-CoV-2 as it exists now.
It’s all harms
Let’s talk about harms from this shot (and remember, it’s all harms in this population because the shot made no difference in real-world health outcomes). And there, things get really weird really fast.
The median study follow-up duration was just 53 days after dose 2. After that, they wiped out the control group. Here’s how they justified it (p. 26):
“Following authorization of an alternative COVID-19 vaccine for this age group on May 10, 2021, participants in the study were permitted to unblind to study treatment. Crossover vaccination with mRNA-1273 of participants initially randomized to placebo began in October 2021.”
For each age category, Moderna spreads the adverse events across 5 different tables to increase the noise to hide the signal. But the bottom line is that the adverse events are off the charts. “In the adolescent population 99.2% of vaccine recipients reported at least one adverse reaction after any injection with 25.3% reporting a reaction that was Grade 3 or higher” (p. 54).
Holy sh*t those numbers are high. Grade 3 means: unable to return to work or school the next day because the person is so sick.
A different FDA staffer must have written the summary statements for the other three age groups because they don’t say it this plainly but the adverse event rates are similar across all of the children.
This adverse event data is so high it’s disqualifying.
But then things get even weirder — the adverse event rates in the placebo group were also very high in many, but not all, categories. Moderna used this to say, ‘well yes, the adverse event rate in the treatment group was higher than anything anyone has ever seen before but the rates were also somewhat high in the placebo group and so, therefore, nothing-to-see-here(TM).’
My strong suspicion is that Moderna rigged the placebo. Why wouldn’t they — the FDA has no regulations concerning the contents of placebos (see Golomb 1995 and Golomb et al. 2010).
The dirty little secret of the vaccine program is that manufacturers almost always use rigged placebos to create an artificially high “background rate” to hide adverse events.
The brilliant quantitative analyst Jessica Rose made a similar observation yesterday in her analysisof the FDA risk-benefit document:
“I still have a very strong suspicion that these ‘placebos’ are not saline and rather empty LNPs. [Lipid nanoparticles — the delivery vehicle that Moderna uses to get mRNA into the cell. An ‘empty LNP’ would be the nanoparticles without the mRNA antigen.]”
I’m almost certain this is what Moderna did. In the 2- through 5-year-old age group 37.5% of placebo recipients reported unsolicited adverse events as compared with 40% of vaccine recipients (see p. 139). A number that high in the placebo group would have been impossible if Moderna had used an inert saline placebo.
The way the FDA rigged the myocarditis data is absolutely sinister
I know that this article is already long but I need to flag one more essential point.
FDA review of the Moderna mRNA shot in adolescents has been held up for a year because the Moderna shot causes myocarditis in this age group — particularly in boys.
So I was curious to see how the FDA would attempt to get around this. And it’s all right there on pages 19 and 20. It’s one of the most chilling things I’ve ever read. The FDA’s argument goes like this:
‘Yes, by the spring and summer of 2021 there were already seven high-quality studies from around the world showing that mRNA shots increase myocarditis risk. By the fall of 2021, the reports continued to come in from the U.K., Europe, Canada, and Nordic countries showing a 2x to 7x increased risk of myocarditis from mRNA shots.
‘Yes, the CDC’s own study of the Vaccine Safety Datalink showed a 2x higher risk of myocarditis from Moderna shots. By May, we have additional studies from the U.K., Denmark, several Nordic countries, Italy, and France showing a 3x to 7x increased risk of myocarditis from the Moderna shot.’
In all, the FDA cited TWENTY-SIX STUDIES showing that mRNA shots in general, and Moderna in particular, increase the risk of myocarditis.
‘But not to worry!’ the FDA announces in the 4th paragraph in this section.
The FDA, CDC, and Kaiser Permanente put their fixers on the case in February and March of this year and made the safety signal shrink down to a more manageable 7% to 50% increased risk of myocarditis and even those results were massaged to make sure that they were not statistically significant, so, nothing-to-see-here(TM).
It was the same fixers who they always use — Tom Shimabukuro and John Su — whose entire job is making vaccine safety signals disappear. Those guys are absolutely going to hell.
‘So that’s that,’ the FDA announces. ‘Just ignore those 26 high-quality studies from around the world showing an increased risk of myocarditis. Our fixers laundered the data for Moderna so we’re all good.’
What is to be done
Children’s Health Defense just launched an excellent 1-click call to action that I highly encourage you to do (and please share it with all of your friends).
Up until tonight (June 13) at 11:59 p.m. Eastern time, you can officially register your profound displeasure with the FDA by submitting a formal comment (here). Look for the blue Comment button in the upper left corner of the website — 129,397 comments have already been received. Let’s see if we can get that number above 140,000.
If you want to write to public health political appointees, FDA staff, and VRBPAC members, all of their email addresses are here:
sean.mccluskie@hhs.gov, commissioner@fda.hhs.gov, DeanofPublicHealth@brown.edu, Aux7@cdc.gov, Peter.Marks@fda.hhs.gov, Hong.Yang@fda.hhs.gov, Richard.Forshee@fda.hhs.gov, Huilee.Wong@fda.hhs.gov, Leslie.Ball@fda.hhs.gov, Doran.Fink@fda.hhs.gov, CBERVRBPAC@fda.hhs.gov, hanae@bcm.edu, paula.annunziato@merck.com, adam.berger@nih.gov, hbernstein@northwell.edu, acohn@cdc.gov, anc0@cdc.gov, hjanes@fredhutch.org, hgans@stanford.edu, david.kim@hhs.gov, asmonto@umich.edu, offit@chop.edu, spergam@fredhutch.org, Jportnoy@cmh.edu, erubin@hsph.harvard.edu, erubin@nejm.org, ashane@emory.edu, swamy002@mc.duke.edu, fullerao@umich.edu, bgellin@rockfound.org, RandyHawkins@cdrewu.edu, officeofthepresident@mmc.edu, JYLee@uams.edu, ofer.levy@childrens.harvard.edu, wayne_marasco@dfci.harvard.edu, cmeissner@tuftsmedicalcenter.org, mrn8d@virginia.edu, stanley-perlman@uiowa.edu, reingold@berkeley.edu, mhsawyer@ucsd.edu, mew2@cdc.gov
Please be polite but let them know that they absolutely must vote NO on the EUA applications from Moderna and Pfizer.
Conclusion
The FDA risk-benefit document in connection with the Moderna mRNA shot in kids is dishonest. The public health establishment has abandoned science, logic, reason, rationality, empathy, health, and medicine.
The FDA is more than happy to sacrifice children in order to ingratiate themselves further with the cartel. The proposal to expand the Moderna EUA to kids 0 to 17 is a crime against humanity.
We are absolutely going to win this fight, either in the short term or in the long term. These shots will eventually be withdrawn from the market because they do not work and cause catastrophic harm.
The members of the VRBAC can save themselves a lot of misery (and additional criminal charges at Nuremberg 2.0) by rejecting these applications from Moderna and Pfizer this week.
Originally published by Toby Rogers on his Substack page, uTobian.
Toby Rogers has a Ph.D. in political economy from the University of Sydney in Australia. His doctoral thesis, “The Political Economy of Autism,” explores the regulatory history of five classes of toxicants that increase autism risk. Rogers shows that the public health problem of autism actually starts with the political economy problem of regulatory capture. He also has a Master of Public Policy degree from the University of California, Berkeley, where he was a researcher for former U.S. Labor Secretary Robert Reich. Rogers now does grassroots political organizing with medical freedom groups across the country working to stop the autism epidemic.
Un pensiero su “FDA Votes YES on Moderna Shots for Kids 6-17yo. Despite the Risk-Benefit Analysis Hides ‘Bad Data’”